Alizé Pharma SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, will present the results from two Phase I clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback